CDC Seeks Reinstatement of Smokeless Tobacco Ingredient Reporting Amidst Public Health Concerns
The Centers for Disease Control and Prevention (CDC) has formally moved to reinstate its longstanding information collection requirement concerning the ingredients and nicotine content in smokeless tobacco products manufactured, imported, or packaged within the United States. This action, published in the Federal Register on June 2, 2026, marks a continuation of a critical public health surveillance effort mandated by federal law, underscoring the government's sustained focus on the health impacts of tobacco.
The Mandate for Disclosure
This data collection stems directly from the Comprehensive Smokeless Tobacco Health Education Act of 1986 (CSTHEA). This legislation, codified at 15 U.S.C. 4401 et seq., charges the Department of Health and Human Services (HHS) with collecting comprehensive information on smokeless tobacco products. HHS, in turn, has delegated this responsibility to the CDC's Office on Smoking and Health (OSH). The central purpose of this mandate is to ensure the federal government has detailed knowledge of what constitutes smokeless tobacco products and their potential health implications, facilitating public health research and policy development.
A "Reinstatement Without Change"
The current Federal Register notice specifically seeks a "Reinstatement without Change" for the information collection project, identified by OMB Control No. 0920-0338. This designation indicates that the CDC is not proposing alterations to the existing reporting requirements or methodology at this time. The continuity of this collection underscores the perceived ongoing necessity of this data for federal health agencies. Respondents, primarily manufacturers, packagers, and importers of smokeless tobacco, are required to submit annual reports detailing ingredients by chemical name and Chemical Abstract Service (CAS) Registration Number, along with nicotine quantity. These reports are due annually on March 31, with new product ingredient reports required at the time of first importation.
Public Health Rationale
The federal government's insistence on this data collection is rooted in significant public health concerns associated with smokeless tobacco. The CDC explicitly highlights several severe health risks, including nicotine addiction; various forms of cancer (mouth, esophagus, pancreas); mouth diseases; risks during pregnancy (early delivery, stillbirth); nicotine poisoning in children; and increased risk of death from heart disease and stroke. The collection of ingredient and nicotine data provides the CDC and HHS with essential information to monitor these products, conduct research into their health effects, and inform Congress and the public about identified dangers. HHS is authorized to use this information to report to Congress on health effects and related research, and to disseminate other information deemed to be of public interest.
The Paperwork Reduction Act Review Process
The current notice initiates a 30-day public comment period, a standard procedure under the Paperwork Reduction Act of 1995. This act requires federal agencies to seek public input on proposed information collections to ensure they are necessary, accurate, and minimize burden on respondents. The Office of Management and Budget (OMB) invites comments on several key aspects: the practical utility of the information, the accuracy of burden estimates, ways to enhance data quality and clarity, and methods to minimize respondent burden, including through technological improvements. Notably, the CDC previously issued a "Proposed Data Collection" notice on September 9, 2025, which did not yield any public comments.
A point of interest for those reviewing the process is the specified submission methods. While the OMB encourages the use of appropriate automated or electronic techniques, the CDC's instructions for this particular collection still include mailing written reports, CDs, three-inch floppy disks, or thumb drives. Electronic mail submissions are explicitly not accepted. This highlights a potential area for future consideration regarding modernizing data submission practices. The CDC estimates the annual burden for respondents to be 18,843 hours, with no costs other than time.
Implications for Industry and Public Policy
For the smokeless tobacco industry, this "reinstatement without change" signifies the continued regulatory expectation for transparent reporting of product constituents. The data provides a foundation for any future regulatory actions or public health campaigns related to smokeless tobacco. For public health advocates and policymakers, the consistent collection of this data remains a vital tool for understanding product evolution, assessing risk, and formulating evidence-based interventions. The opportunity for public comment, though largely overlooked in the previous round, offers a chance for industry stakeholders, public health organizations, and the general public to influence the practical aspects of this ongoing federal surveillance.
